PRGN-3005: Cancer
| Source | Web search |
|---|---|
| Organization | Intrexon |
| Website URL | precigen.com/pipeline/ |
| Market status | Under Development |
| Industry | Medical |
| Value chain stage | Finished Product |
| Business models | B2B |
| Product categories | Medical Treatment |
| Biotech components | Gene Editing + Molecule |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Trading symbol | XON |
| Trading exchange | NASDAQ |
| Questions? | Does the process of electroporation of a plasmid into a T-cell count as gene "editing"? (platform used here is called CAR-T https://precigen.com/science/#id-plattech) |